• LIVERFASt
  • Patients
  • About us
  • Resources
    • Publications
    • Blog
    • News
    • Brochures
  • Contact us
  • LIVERFASt
  • Patients
  • About us
  • Resources
    • Publications
    • Blog
    • News
    • Brochures
  • Contact us
Portal login

Application of LIVERFASt biomarkers to evaluate longitudinal hepatic fibrosis and inflammation after HCV cure

easlfibronostg on June 26, 2026

Application of LIVERFASt biomarkers to evaluate longitudinal hepatic fibrosis and inflammation after HCV cure

Application of LIVERFASt to predict steatosis in Chronic Hepatitis B patients with metabolic syndrome

easlfibronostg on June 26, 2026

Application of LIVERFASt to predict steatosis in Chronic Hepatitis B patients with metabolic syndrome

LIVERFASt Demonstrates the Feasibility of a Screening Program for MASLD

easlfibronostg on June 25, 2026

LIVERFASt Demonstrates the Feasibility of a Screening Program for MASLD

Posts pagination

Previous 1 2 3

US Headquarters

  • 615 Baronne St, Suite 100 New Orleans LA 70113
  • 1-888-552-1603

Asia Headquarters

  • 79 Science Park Drive, Cintech IV, #06-01/08 Singapore 118264
  • + 65 6817 6290
  • service@fibronostics.com
Linkedin Facebook Instagram

Gain insights into your patients’liver health today

© 2026 Fibronostics. All rights reserved.

  • Trust Center
  • Cookie Policy
  • Terms of Use